Log in | Register

Critical research on biomarkers: what’s new?

Matthieu Legrand| James L. Januzzi Jr| Alexandre Mebazaa
What's New in Intensive Care
Volume 39, Issue 10 / October , 2013

Pages 1824 - 1828

No abstract available.

References

  1. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333–1340. doi:10.1007/s00134-010-1887-4
  2. Valette X, Savary B, Nowoczyn M et al (2013) Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness. Intensive Care Med 39:857–865. doi:10.1007/s00134-013-2826-y
  3. Legrand M, Collet C, Gayat E et al (2013) Accuracy of urine NGAL commercial assays in critically ill patients. Intensive Care Med 39:541–542. doi:10.1007/s00134-012-2788-5
  4. Mårtensson J, Xu S, Bell M, Martling CR, Venge P (2012) Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 413:1661–1667. doi:10.1016/j.cca.2012.05.010
    • View reference on PubMed
    • View reference on publisher's website
  5. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28:254–273. doi:10.1093/ndt/gfs380
    • View reference on PubMed
    • View reference on publisher's website
  6. Royakkers AANM, Korevaar JC, van Suijlen JDE et al (2011) Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intens Care Med 37:493–501. doi:10.1007/s00134-010-2087-y
  7. Orenes-Piñero E, Manzano-Fernández S, López-Cuenca A, Marín F, Valdés M, Januzzi JL (2013) β-trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol 8:873–881. doi:10.2215/CJN.08870812
    • View reference on PubMed
    • View reference on publisher's website
  8. Maisel AS, Mueller C, Fitzgerald R et al (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL evaLuation along with B-type NaTriuretic peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 13:846–851. doi:10.1093/eurjhf/hfr087
    • View reference on PubMed
    • View reference on publisher's website
  9. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling C-R (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333–1340. doi:10.1007/s00134-010-1887-4
  10. Nejat M, Pickering JW, Devarajan P et al (2012) Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 81:1254–1262. doi:10.1038/ki.2012.23
    • View reference on PubMed
    • View reference on publisher's website
  11. Vaidya VS, Ozer JS, Dieterle F et al (2010) Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478–485. doi:10.1038/nbt.1623
    • View reference on PubMed
    • View reference on publisher's website
  12. Haaf P, Drexler B, Reichlin T et al (2012) High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac non coronary artery disease. Circulation 126:31–40. doi:10.1161/CIRCULATIONAHA.112.100867
    • View reference on PubMed
    • View reference on publisher's website
  13. Bajwa EK, Boyce PD, Januzzi JL, Gong MN, Thompson BT, Christiani DC (2007) Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med 35:2484–2490
    • View reference on PubMed
    • View reference on publisher's website
  14. Ouanes-Besbes L, Dachraoui F, Ouanes I et al (2012) NT-proBNP levels at spontaneous breathing trial help in the prediction of post-extubation respiratory distress. Intensive Care Med 38:788–795. doi:10.1007/s00134-012-2524-1
  15. Mekontso Dessap A, Roche-Campo F, Kouatchet A et al (2012) Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 186:1256–1263. doi:10.1164/rccm.201205-0939OC
    • View reference on PubMed
    • View reference on publisher's website
  16. Januzzi JL Jr (2013) ST2 as a cardiovascular risk biomarker: from the bench to the bedside. J Cardiovasc Transl Res. doi:10.1007/s12265-013-9459-y
    • View reference on PubMed
  17. Bajwa E, Volk J, Christiani D et al (2013) Prognostic and diagnostic value of plasma soluble ST2 concentrations in acute lung injury. Crit Care Med (in press)
  18. Røsjø H, Nygård S, Kaukonen K-M et al (2012) Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study. Intensive Care Med 38:820–829. doi:10.1007/s00134-012-2546-8
  19. Bossuyt PM, Reitsma JR, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138:W1–W12

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement